Health News

Up in the Air, Radiation Exposure Was Higher
Pilots and cabin crew members may want to make sure sunscreen is part of their pre-flight routine.
Pill Problems: Some Patients May Not Need Anti-Anxiety Rx
They relieve anxiety and help many patients sleep, but benzodiazepines might not be the best choice for many patients — especially over the long term. Still, many older patients were taking these medications. 
Migraine Patients May Face Facial Paralysis Risk
Migraine patients may have another headache to worry about. Migraines may be connected to a treatable type of facial paralysis.
New Treatment Helped More Patients Ditch Nicotine
If you can fight fire with fire, why not fight addiction to nicotine with another chemical?
Amgen's Leukemia Rx is Effective & Expensive
Earlier this month, the US Food and Drug Administration (FDA) approved a new type of treatment for a severe form of leukemia. That treatment becomes available Thursday, and the manufacturer has revealed how much it will cost.
Holiday Menus for Diabetes Patients
The holidays are a time of celebration, family and a lot of sweet, salty and fatty foods. And although they have dietary restrictions, diabetes patients can still safely enjoy holiday food — with a few simple substitutions and some smaller portions.
FDA Approved Somatuline Depot Injection for Pancreatic and Gastrointestinal Neuroendorcine Tumors
Ipsen (Euronext: IPN; ADR: IPSEY) today announced that Somatuline® Depot® (lanreotide) Injection 120 mg (referred to as Somatuline®) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Novogen Announces Breakthrough Discovery in the Treatment of Melanoma
Novogen Limited, Australian/US biotechnology company, today announces that it has confirmed that its lead candidate product, TRXE-009, originally developed for the treatment of brain cancers, has been shown in pre-clinical studies also to be highly active against melanoma.
Novartis Gains FDA Approval for Signifor LAR
Novartis announced today that the US Food and Drug Administration (FDA) has approved Signifor® long-acting release (LAR)* (pasireotide) for injectable suspension, for intramuscular use, for the treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option.
FDA Approves First Pathogen Reduction System to Treat Plasma
The U.S. Food and Drug Administration today approved the Intercept Blood System for plasma, the first pathogen reduction system for use by blood establishments in the preparation of plasma in order to reduce the risk of transfusion-transmitted infections (TTI).
<< first309310311312313314315316317last >>

REFINE